How often should I be screened after Pancreatic Cancer treatment

Follow-Up Screening After Pancreatic Cancer Treatment

This is an important question, and the answer depends on several factors specific to your situation. Let me explain what the current evidence shows about monitoring after treatment.

What the Guidelines Recommend

According to Let's Win Pancreatic Cancer resources and current medical practice, there isn't a one-size-fits-all screening schedule for all pancreatic cancer patients after treatment. Instead, your follow-up plan should be individualized based on:

• Your cancer stage at diagnosis
• Type of treatment you received (surgery, chemotherapy, etc.)
• Genetic mutations in your tumor or inherited genes
• Whether you had surgery to remove the cancer
• Your overall health and ability to tolerate monitoring

Key Monitoring Approaches

Blood Tests

Your oncologist will likely track CA 19-9 levels regularly. According to the guidelines, CA 19-9 is the most extensively studied biomarker for pancreatic cancer. Here's what to know:

• Higher CA 19-9 levels typically indicate active disease
• Decreasing levels suggest treatment is working
• Regular blood work helps detect any recurrence early

Imaging Studies

Depending on your specific case, you may have:

• CT scans - typically the best way to see if cancer has returned
• MRI or MRCP - for detailed imaging of the pancreas and bile ducts
• Frequency varies - some patients get scans every 3-6 months initially, then less frequently if stable

Important Questions to Ask Your Oncology Team

Since your specific follow-up schedule needs to be personalized, ask your doctor:

1. "What is my specific follow-up schedule for the next 1-2 years?" (Get this in writing)
2. "How often should I have CA 19-9 blood tests, and what numbers should concern us?"
3. "What imaging studies do you recommend, and how frequently?"
4. "What symptoms should I report immediately between appointments?" (weight loss, jaundice, pain, etc.)
5. "Should I have genetic testing if I haven't already, and does that change my monitoring?"

Why Early Detection Matters

According to Let's Win Pancreatic Cancer, surveillance programs for high-risk patients have shown impressive results:

• In one study, 9 out of 9 pancreatic cancers detected during surveillance were operable (could be surgically removed)
• These patients had an 85% three-year survival rate
• When pancreatic cancer is caught early (Stage I), outcomes are "radically different" compared to advanced disease

This emphasizes why consistent follow-up monitoring is so valuable—catching any recurrence as early as possible makes a real difference.

Multidisciplinary Care is Key

According to the guidelines, "Patients who have pancreatic cancer really need to seek treatment from a high-volume center." This applies to follow-up care too. A multidisciplinary team (oncologist, surgeon, gastroenterologist, and others) can help guide your monitoring plan and catch any changes early.

Long-Term Monitoring Considerations

• Years 1-2: More frequent monitoring (every 3-6 months)
• Years 3+: May transition to less frequent visits if stable
• Ongoing: Regular check-ins even years after treatment, as late recurrences can occur

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncology team knows your complete medical picture and can create a monitoring plan tailored specifically to your situation. Don't hesitate to ask for a written summary of your follow-up schedule so you have it for reference and to share with other doctors if needed.